Morgan Stanley, BofA Securities, Cantor and RBC Capital Markets are acting as joint book running managers for the offering.

MaxCyte inks strategic platform license agreement with TG Therapeutics to advance its autoimmune cell therapeutics programmes: Rockville, Maryland Thursday, February 13, 2025, 10: ...